Last Updated: September 28, 2026

Macleods Pharms Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for MACLEODS PHARMS

MACLEODS PHARMS has one hundred and sixty approved drugs.

There are thirteen tentative approvals on MACLEODS PHARMS drugs.

Summary for Macleods Pharms

US Patents:	0
Tradenames:	132
Ingredients:	131
NDAs:	160

Drugs and US Patents for Macleods Pharms

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Macleods Pharms	ATORVASTATIN CALCIUM	atorvastatin calcium	TABLET;ORAL	208480-003	Jun 3, 2024	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Macleods Pharms	EFAVIRENZ	efavirenz	TABLET;ORAL	091579-001	May 10, 2024	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Macleods Pharms	RIVAROXABAN	rivaroxaban	TABLET;ORAL	213114-001	May 14, 2025	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Macleods Pharms	LOPINAVIR AND RITONAVIR	lopinavir; ritonavir	TABLET;ORAL	204739-001	Jul 25, 2024	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Macleods Pharms	MONTELUKAST SODIUM	montelukast sodium	TABLET, CHEWABLE;ORAL	203582-002	Mar 12, 2015	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Macleods Pharms	VARDENAFIL HYDROCHLORIDE	vardenafil hydrochloride	TABLET, ORALLY DISINTEGRATING;ORAL	205988-001	Mar 10, 2020	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for MACLEODS PHARMS drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	for Injection	200 mcg/vial	➤ Subscribe	2015-05-01
➤ Subscribe	for Injection	100 mcg/vial and 500 mcg/vial	➤ Subscribe	2015-04-14

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.